Amgen Inc (AMGN)
299.55
-11.74
(-3.77%)
USD |
NASDAQ |
May 06, 16:00
299.38
-0.17
(-0.06%)
After-Hours: 20:00
Amgen Market Cap: 160.69B for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 06, 2024 | 160.69B |
| May 03, 2024 | 166.99B |
| May 02, 2024 | 149.34B |
| May 01, 2024 | 148.79B |
| April 30, 2024 | 146.95B |
| April 29, 2024 | 148.26B |
| April 26, 2024 | 144.81B |
| April 25, 2024 | 144.49B |
| April 24, 2024 | 146.44B |
| April 23, 2024 | 146.72B |
| April 22, 2024 | 145.85B |
| April 19, 2024 | 144.25B |
| April 18, 2024 | 140.93B |
| April 17, 2024 | 141.64B |
| April 16, 2024 | 142.48B |
| April 15, 2024 | 142.41B |
| April 12, 2024 | 143.36B |
| April 11, 2024 | 144.82B |
| April 10, 2024 | 142.92B |
| April 09, 2024 | 145.01B |
| April 08, 2024 | 144.39B |
| April 05, 2024 | 144.79B |
| April 04, 2024 | 143.80B |
| April 03, 2024 | 147.19B |
| April 02, 2024 | 148.15B |
| Date | Value |
|---|---|
| April 01, 2024 | 151.82B |
| March 28, 2024 | 152.37B |
| March 27, 2024 | 153.43B |
| March 26, 2024 | 151.01B |
| March 25, 2024 | 150.50B |
| March 22, 2024 | 148.00B |
| March 21, 2024 | 148.42B |
| March 20, 2024 | 146.33B |
| March 19, 2024 | 145.63B |
| March 18, 2024 | 145.18B |
| March 15, 2024 | 144.09B |
| March 14, 2024 | 145.52B |
| March 13, 2024 | 147.91B |
| March 12, 2024 | 148.20B |
| March 11, 2024 | 147.57B |
| March 08, 2024 | 146.71B |
| March 07, 2024 | 146.23B |
| March 06, 2024 | 148.23B |
| March 05, 2024 | 148.26B |
| March 04, 2024 | 149.73B |
| March 01, 2024 | 150.23B |
| February 29, 2024 | 146.75B |
| February 28, 2024 | 148.70B |
| February 27, 2024 | 149.25B |
| February 26, 2024 | 153.47B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
101.68B
Minimum
May 31 2019
173.77B
Maximum
Feb 01 2024
133.02B
Average
132.93B
Median
Jun 17 2020
Market Cap Benchmarks
| Gilead Sciences Inc | 81.74B |
| Johnson & Johnson | 357.58B |
| Eli Lilly and Co | 728.66B |
| Merck & Co Inc | 323.11B |
| Vertex Pharmaceuticals Inc | 103.97B |
Market Cap Related Metrics
| PE Ratio | 42.79 |
| PS Ratio | 5.450 |
| Price to Book Value | 32.00 |
| Price to Free Cash Flow | 22.67 |
| Price | 299.55 |
| Earnings Yield | 2.34% |
| Operating PE Ratio | 23.10 |
| Normalized PE Ratio | 42.79 |